Home > Insider Trading > Filing (0001562180-22-002166)

Filing Details

Accession Number:: 0001562180-22-002166
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-02 21:25:01
Reporting Period:: 2022-02-28

Accepted Time:: 2022-03-02 21:25:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1517022	Akebia Therapeutics Inc.	AKBA	Pharmaceutical Preparations (2834)	208756903

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591467	P. John Butler	C/O Akebia Therapeutics, Inc. 245 First Street Cambridge MA 02142	Ceo And President	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2022-02-28	25,053	$2.15	1,164,095	No	4	S	Direct
Common Stock	Acquisiton	2022-02-28	293,125	$0.00	1,457,220	No	4	A	Direct
Common Stock	Disposition	2022-03-01	24,811	$2.17	1,432,409	No	4	S	Direct
Common Stock	Disposition	2022-03-01	25,031	$2.17	1,407,378	No	4	S	Direct
Common Stock	Disposition	2022-03-01	4,131	$2.17	1,403,247	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to buy)	Acquisiton	2022-02-28	739,700	$0.00	739,700	$2.16

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
739,700		2032-02-28	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	59,928	Indirect	Held by Dorothy Butler 2019 GRAT
Common Stock	100,000	Indirect	Held By Dorothy Butler GRAT November 2019
Common Stock	59,928	Indirect	Held by John Butler 2019 GRAT
Common Stock	100,000	Indirect	Held By John Butler GRAT November 2019

Footnotes

This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.
Includes: (i) the 1,248 shares of common stock that were described in the amendment on Form 4/A filed by the reporting person with the SEC on February 18, 2022, (ii) 1,500 shares of the Issuer's common stock purchased on each of June 30, 2021 and December 31, 2021, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan, and (iii) 32,747 shares of common stock that represent a change from indirect to direct ownership of shares previously reported as beneficially owned by the reporting person.
The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.
This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019.
This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.
The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.